|Day's Range||0.00 - 0.00|
|52 Week Range|
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK, NY / ACCESSWIRE / January 25, 2016 / If you're an investor in Pernix (PTX), Durect (DRRX) or any one of the dozen plus companies developing tamper-resistant technology for opioid drugs, you might ...
NEW YORK, NY / ACCESSWIRE / January 20, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Kingfisher ...
NEW YORK, NY / ACCESSWIRE / January 12, 2016 / Rite-Aid & CVS recently stated they will sell naloxone over-the-counter, creating a tailwind for Lightlake Therapeutics ( LLTP ) as its commercial partner ...